Bausch Historical Income Statement

BHC Stock

CAD 10.71 0.07 0.66%

Historical analysis of Bausch Health income statement accounts such as Interest Expense of 1.4 B, Selling General Administrative of 2.4 B or Total Revenue of 9.2 B can show how well Bausch Health Companies performed in making a profits. Evaluating Bausch Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bausch Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bausch Health Companies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bausch Health Companies is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Bausch Income Statement Analysis

Bausch Health Companies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bausch Health shareholders. The income statement also shows Bausch investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bausch Health Income Statement Chart

At this time, Bausch Health's EBIT is very stable compared to the past year. As of the 22nd of December 2024, Cost Of Revenue is likely to grow to about 2.7 B, while Depreciation And Amortization is likely to drop about 883.6 M.

Depreciation And Amortization Gross Profit Research Development Selling And Marketing Expenses Net Income From Continuing Ops Net Income Applicable To Common Shares

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Bausch Health Companies minus its cost of goods sold. It is profit before Bausch Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.

Most accounts from Bausch Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Gross Profit	6.0B	5.8B	6.2B	6.5B
Total Revenue	8.4B	8.1B	8.8B	9.2B

Gross Profit Total Revenue

Bausch Health income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.83	0.64	0.74	0.74	0.77	-0.3	-0.14	0.49	0.73	0.77	-0.65	-0.83	-0.25	-0.42	0.4	0.6	-0.36	0.06	-0.47	0.23	-0.16	0.2	0.28
Interest Expense	0.83		0.94	0.93	0.93	0.96	-0.06	0.04	0.51	0.93	0.96	-0.54	-0.85	-0.28	-0.25	0.78	0.87	-0.5	-0.43	-0.37	-0.18	0.36	-0.32	-0.1
Selling General Administrative	0.64	0.94		0.96	0.95	0.96	0.16	0.21	0.53	0.97	0.95	-0.33	-0.77	-0.22	-0.08	0.91	0.93	-0.46	-0.61	-0.21	-0.38	0.57	-0.53	-0.35
Total Revenue	0.74	0.93	0.96		1.0	0.98	0.19	0.28	0.66	0.99	0.96	-0.29	-0.8	-0.2	-0.06	0.84	0.94	-0.43	-0.42	-0.17	-0.25	0.39	-0.36	-0.23
Gross Profit	0.74	0.93	0.95	1.0		0.97	0.2	0.29	0.67	0.98	0.95	-0.28	-0.8	-0.21	-0.05	0.84	0.94	-0.44	-0.4	-0.16	-0.23	0.37	-0.34	-0.21
Other Operating Expenses	0.77	0.96	0.96	0.98	0.97		0.05	0.12	0.53	0.98	1.0	-0.43	-0.84	-0.27	-0.13	0.84	0.92	-0.48	-0.44	-0.23	-0.24	0.42	-0.37	-0.25
Operating Income	-0.3	-0.06	0.16	0.19	0.2	0.05		0.97	0.66	0.17	-0.01	0.86	0.21	0.63	0.15	0.26	0.24	0.48	-0.29	0.1	-0.29	0.28	-0.41	-0.21
Ebit	-0.14	0.04	0.21	0.28	0.29	0.12	0.97		0.79	0.24	0.07	0.78	0.07	0.61	0.08	0.3	0.31	0.45	-0.23	0.03	-0.24	0.2	-0.33	-0.1
Ebitda	0.49	0.51	0.53	0.66	0.67	0.53	0.66	0.79		0.61	0.49	0.3	-0.42	0.39	-0.19	0.45	0.61	0.19	-0.13	-0.27	-0.02	0.04	-0.14	0.17
Cost Of Revenue	0.73	0.93	0.97	0.99	0.98	0.98	0.17	0.24	0.61		0.95	-0.31	-0.78	-0.19	-0.1	0.83	0.91	-0.39	-0.48	-0.2	-0.3	0.45	-0.41	-0.28
Total Operating Expenses	0.77	0.96	0.95	0.96	0.95	1.0	-0.01	0.07	0.49	0.95		-0.48	-0.86	-0.31	-0.13	0.83	0.91	-0.52	-0.42	-0.24	-0.22	0.4	-0.35	-0.23
Income Before Tax	-0.65	-0.54	-0.33	-0.29	-0.28	-0.43	0.86	0.78	0.3	-0.31	-0.48		0.6	0.7	0.22	-0.17	-0.23	0.68	0.02	0.25	-0.17	0.02	-0.14	-0.16
Total Other Income Expense Net	-0.83	-0.85	-0.77	-0.8	-0.8	-0.84	0.21	0.07	-0.42	-0.78	-0.86	0.6		0.31	0.28	-0.64	-0.69	0.46	0.13	0.36	0.13	-0.15	0.07	0.05
Net Income	-0.25	-0.28	-0.22	-0.2	-0.21	-0.27	0.63	0.61	0.39	-0.19	-0.31	0.7	0.31		-0.54	-0.23	-0.24	0.94	0.13	-0.51	-0.01	-0.19	0.07	-0.01
Income Tax Expense	-0.42	-0.25	-0.08	-0.06	-0.05	-0.13	0.15	0.08	-0.19	-0.1	-0.13	0.22	0.28	-0.54		0.13	0.06	-0.49	-0.16	0.98	-0.2	0.29	-0.26	-0.19
Research Development	0.4	0.78	0.91	0.84	0.84	0.84	0.26	0.3	0.45	0.83	0.83	-0.17	-0.64	-0.23	0.13		0.88	-0.46	-0.67	0.01	-0.52	0.69	-0.65	-0.49
Selling And Marketing Expenses	0.6	0.87	0.93	0.94	0.94	0.92	0.24	0.31	0.61	0.91	0.91	-0.23	-0.69	-0.24	0.06	0.88		-0.49	-0.53	-0.07	-0.31	0.51	-0.49	-0.28
Net Income From Continuing Ops	-0.36	-0.5	-0.46	-0.43	-0.44	-0.48	0.48	0.45	0.19	-0.39	-0.52	0.68	0.46	0.94	-0.49	-0.46	-0.49		0.29	-0.4	0.09	-0.33	0.21	0.07
Minority Interest	0.06	-0.43	-0.61	-0.42	-0.4	-0.44	-0.29	-0.23	-0.13	-0.48	-0.42	0.02	0.13	0.13	-0.16	-0.67	-0.53	0.29		-0.07	0.53	-0.93	0.94	0.45
Tax Provision	-0.47	-0.37	-0.21	-0.17	-0.16	-0.23	0.1	0.03	-0.27	-0.2	-0.24	0.25	0.36	-0.51	0.98	0.01	-0.07	-0.4	-0.07		-0.14	0.2	-0.18	-0.18
Interest Income	0.23	-0.18	-0.38	-0.25	-0.23	-0.24	-0.29	-0.24	-0.02	-0.3	-0.22	-0.17	0.13	-0.01	-0.2	-0.52	-0.31	0.09	0.53	-0.14		-0.77	0.71	0.73
Net Interest Income	-0.16	0.36	0.57	0.39	0.37	0.42	0.28	0.2	0.04	0.45	0.4	0.02	-0.15	-0.19	0.29	0.69	0.51	-0.33	-0.93	0.2	-0.77		-0.97	-0.61
Reconciled Depreciation	0.2	-0.32	-0.53	-0.36	-0.34	-0.37	-0.41	-0.33	-0.14	-0.41	-0.35	-0.14	0.07	0.07	-0.26	-0.65	-0.49	0.21	0.94	-0.18	0.71	-0.97		0.5
Extraordinary Items	0.28	-0.1	-0.35	-0.23	-0.21	-0.25	-0.21	-0.1	0.17	-0.28	-0.23	-0.16	0.05	-0.01	-0.19	-0.49	-0.28	0.07	0.45	-0.18	0.73	-0.61	0.5

Click cells to compare fundamentals

Bausch Health Account Relationship Matchups

Bausch Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.9B	1.8B	1.6B	1.4B	1.3B	883.6M
Interest Expense	1.6B	1.5B	1.4B	1.5B	1.3B	1.4B
Selling General Administrative	2.0B	1.9B	2.1B	2.1B	2.3B	2.4B
Total Revenue	8.6B	8.0B	8.4B	8.1B	8.8B	9.2B
Gross Profit	6.3B	5.8B	6.0B	5.8B	6.2B	6.5B
Other Operating Expenses	8.7B	6.7B	7.2B	6.8B	7.8B	8.2B
Operating Income	(73M)	676M	1.2B	1.4B	963M	1.0B
Ebit	(47M)	1.3B	1.7B	1.5B	938M	984.9M
Ebitda	1.9B	3.1B	3.3B	2.9B	2.2B	1.3B
Cost Of Revenue	2.4B	2.2B	2.4B	2.4B	2.6B	2.7B
Total Operating Expenses	6.3B	4.5B	4.8B	4.4B	5.2B	5.5B
Income Before Tax	(1.8B)	(934M)	(1.0B)	(129M)	(390M)	(409.5M)
Total Other Income Expense Net	(1.6B)	(1.6B)	(1.5B)	(583M)	(1.4B)	(1.3B)
Net Income	(1.8B)	(559M)	(937M)	(212M)	(592M)	(562.4M)
Income Tax Expense	(54M)	(375M)	(87M)	83M	221M	232.1M
Research Development	471M	452M	465M	529M	604M	634.2M
Selling And Marketing Expenses	544M	451M	515M	518M	625M	520.8M
Net Income From Continuing Ops	(1.8B)	(559M)	(937M)	(212M)	(611M)	(641.6M)
Net Income Applicable To Common Shares	(1.8B)	(560M)	(948M)	(225M)	(202.5M)	(212.6M)
Minority Interest	73M	70M	(11M)	(13M)	19M	18.1M
Tax Provision	(54M)	(375M)	(87M)	83M	221M	232.1M
Interest Income	1.6B	13M	1.4B	1.5B	26M	24.7M
Net Interest Income	(1.6B)	(1.5B)	(1.4B)	(1.5B)	(1.3B)	(1.4B)
Reconciled Depreciation	2.1B	1.8B	1.4B	1.4B	1.3B	1.6B

Pair Trading with Bausch Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.

Moving against Bausch Stock

0.46	BRY	Bri Chem Corp	Pair Corr
0.43	AAPL	Apple Inc CDR	Pair Corr
0.33	SEC	Senvest Capital	Pair Corr
0.31	NPTH	NeuPath Health	Pair Corr

The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.

The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:

How To Invest In Bausch

Details

Is Bausch Stock a good investment?

Details

What is Bausch Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bausch Historical Income Statement

About Bausch Income Statement Analysis

Bausch Health Income Statement Chart

Depreciation And Amortization

Gross Profit

Net Income Applicable To Common Shares

Bausch Health income statement Correlations

Bausch Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bausch Health income statement Accounts

Pair Trading with Bausch Health

Moving against Bausch Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Cost Of Revenue	+ 0.99	Total Revenue
Other Operating Expenses	+ 0.98	Total Revenue
Cost Of Revenue	+ 0.98	Gross Profit
Cost Of Revenue	+ 0.98	Other Operating Expenses

Reconciled Depreciation	- 0.97	Net Interest Income
Net Interest Income	- 0.93	Minority Interest
Total Other Income Expense Net	- 0.86	Total Operating Expenses
Total Other Income Expense Net	- 0.85	Interest Expense
Total Other Income Expense Net	- 0.84	Other Operating Expenses
Total Other Income Expense Net	- 0.83	Depreciation And Amortization